NeuSpera Medical
2841 Junction Avenue
Suite 101
San Jose, CA 95134
California
95134
United States
Tel: 888-846-8332
Website: http://neuspera.com/
About NeuSpera Medical
Neuspera Medical, headquartered in San Jose, CA, is committed to bringing forward implantable medical device technology that will improve lives of patients battling with chronic illness.
YEAR FOUNDED:
2013
LEADERSHIP:
Founder and CTO: Alexander Yeh
CEO: Milton M. Morris
JOBS:
7 articles with NeuSpera Medical
-
Money on the Move: July 14 – 21
7/21/2021
More money means more progress for potentially life-saving therapies. Here's a peek at some biopharma companies adding to their books this week. -
Neuspera Medical Announces Close of a $65M Series C Equity Financing
7/20/2021
Neuspera Medical Inc. today announced the closing of the company's $65 million series C equity financing. The Series C round was co-led by Vertex Ventures HC and Treo Ventures.
-
Clinical Catch-Up: June 8-12
6/15/2020
It was a fairly busy week with clinical trial updates and announcements. Here’s a look. -
Neuspera Medical Completes First Implants of its Neuromodulation Device in its two-stage Pivotal Clinical Trial to treat Urinary Urgency Incontinence
6/10/2020
Neuspera Medical Inc., a privately held, clinical stage medical device company, today announced the completion of the first chronic clinical implants of the Neuspera Neuromodulation System on the sacral nerve. The ultra-miniaturized device
-
Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
12/10/2019
Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption from the FDA – enabling the company to conduct the first long-term clinical trial of its ultra-miniaturized neuromodulation platform.
-
Neuspera Medical Announces Final Close of $26M Series B Equity Financing
2/20/2019
Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, announced the final closing (2nd tranche) of the company's Series B equity financing.
-
Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
1/24/2018
The $26M financing was led by 6 Dimensions Capital with all existing investors from Series A also participating including Action Potential Venture Capital and Windham Venture Partners.